Pregnancy and Cardiomyopathy After Anthracyclines in Childhood
Open Access
- 26 March 2018
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 5, 14
Abstract
With advances in cancer therapy, there has been a remarkable increase in survival in children diagnosed with malignancies. Many of these children are treated with anthracyclines which are well known to cause cardiotoxicity. As more childhood cancer survivors reach childbearing age, many will choose to become pregnant. At this time, the factors associated with development of cardiomyopathy after anthracycline treatment are not clearly identified. It is possible that cardiac stress could predispose to cardiac deterioration in a patient with reduced functional reserve from prior anthracycline exposure. Pregnancy is one form of cardiovascular stress. The cardiac outcomes of pregnancy in childhood cancer survivors must be considered. In view of limited data, guidelines for pregnancy planning, management, and monitoring after cardiotoxic cancer therapy have not been established. This review summarizes the limited data available on the topic of pregnancy after anthracyclines in childhood.Keywords
This publication has 24 references indexed in Scilit:
- Identification of the molecular basis of doxorubicin-induced cardiotoxicityNature Medicine, 2012
- Pregnancy in Patients With Pre-Existing CardiomyopathiesJACC, 2011
- Anthracycline associated cardiotoxicity in survivors of childhood cancerHeart, 2008
- Monitoring for Cardiovascular Disease in Survivors of Childhood Cancer: Report From the Cardiovascular Disease Task Force of the Children's Oncology GroupPediatrics, 2008
- Clinical heart failure during pregnancy and delivery in a cohort of female childhood cancer survivors treated with anthracyclinesEuropean Journal of Cancer, 2006
- Prospective Multicenter Study of Pregnancy Outcomes in Women With Heart DiseaseCirculation, 2001
- Peripartum Cardiomyopathy Occurring in a Patient Previously Treated With DoxorubicinThe American Journal of the Medical Sciences, 1997
- Female Sex and Higher Drug Dose as Risk Factors for Late Cardiotoxic Effects of Doxorubicin Therapy for Childhood CancerNew England Journal of Medicine, 1995
- Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in ChildhoodNew England Journal of Medicine, 1991
- Effects of a natural volume overload state (pregnancy) on left ventricular performance in normal human subjects.Circulation, 1978